Article Text

Download PDFPDF
Carcinoma of the bronchus 60 years later
  1. G A Silvestri1,
  2. S G Spiro2
  1. 1
    Medical University of South Carolina, Charleston, SC, USA
  2. 2
    Department of Thoracic Medicine, Middlesex Hospital, London, UK
  1. Dr G A Silvestri, Division of Pulmonary and Critical Care Medicine, 96 Jonathan Lucas Street, Suite 812, P O Box 250623, Charleston, SC 29425, USA; silvestri{at}

Statistics from

The subject of malignant disease of the lung, particularly bronchogenic carcinoma, appears to be a suitable one for such an occasion as this for many reasons. It is a condition of considerable importance owing to its increasing incidence; it clearly illustrates the advance in diagnosis and treatment in chest disease obtained during the last 20 years. It affords, in all its various aspects, opportunities to all sections of this association for study, and, lastly, it is a subject which has always been of considerable interest to me personally (excerpt from A Tudor Edwards).1

Above the readers of today’s Thorax will find the introduction to the first article ever published in this journal. The article was written by A Tudor Edwards and is based upon his presidential address to the association for the study of diseases of the chest on 27 July 1945. Despite the fact that this address was given 60 years ago and about 2 months after VE day celebrations signalling the end of World War II, it could just as easily have been given in the year 2006. For certain, lung cancer is a condition of considerable importance in the world today. It is the leading cause of preventable cancer death worldwide. Clearly, there have been advances in the diagnosis, staging, and treatment over the past 60 years. As asserted by Tudor Edwards 60 years ago, lung cancer lends itself to a multidisciplinary approach with respiratory physicians, thoracic surgeons, oncologists, and radiotherapists working jointly to study the disease while providing comprehensive cancer care.

Throughout the remainder of this article we will endeavour to provide an update in lung cancer while paying particular attention to how far we have come from then until now. Where possible we will use excerpts from the original article (in italics) to …

View Full Text


  • None declared.

  • This is a reprint of a paper that appeared in Thorax, December 2006, volume 61, pages 1023–8. Reprinted with kind permission of the authors and publisher.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.